Public health agency the US Food and Drug Administration announced on Friday that it has approved the marketing of the first duodenoscope in the US with a sterile, disposable elevator component that will reduce the number of parts that need to be cleaned and disinfected in between uses under its premarket clearance (510(k)) pathway.
The FDA reportedly granted clearance of the ED34-i10T2 to Pentax of America.
Additionally, the agency stated the Pentax Medical Video ED34-i10T2 model duodenoscope is intended to to be used with endoscopic devices and provide visualization and access to the upper gastrointestinal (GI) tract to treat bile duct disorders and other upper GI problems. The first duodenoscope with disposable elevator piece reduces the number of parts needing disinfection.
In August, the FDA released a safety communication recommending that duodenoscope manufacturers and health care facilities transition to duodenoscopes with disposable components. Disposable designs can simplify or eliminate the need for reprocessing of certain components, which may reduce between-patient duodenoscope contamination.
This FDA clearance is the first duodenoscope device with a disposable elevator component -- a part that has been traditionally difficult to clean and reprocess.
Laronix and Greater Baltimore Medical Center launch Laronix MIRA Voice investigational study
BD receives CE Mark for Revello vascular covered stent
GAIA and Daiichi Sankyo Europe partner on digital therapeutic for cardiovascular care
Airiver Medical's Airiver Pulmonary DCB receives US FDA Breakthrough Device Designation
BD receives FDA clearance for Surgiphor 1000mL irrigation system
Galderma secures EU, US and Canada approval for new Restylane syringe
Organon licenses MIUDELLA IUD from Sebela Pharmaceuticals
Advita Ortho updates Chime clinical exchange application
Philips launches InkSpace Imaging Snuggle coil for 3.0T MRI systems
Realheart secures European patent for artificial heart technology
Median Technologies secures FDA clearance for AI lung cancer screening software
Eli Lilly to invest over USD3.5bn in new Pennsylvania plant
Spine Innovation's LOGIC Titanium Implant System receives US FDA 510(k) market approval
Apiject to open new generic injectable drug manufacturing facility in Apex, NC
Zylox-Tonbridge agrees staged acquisition of Germany's Optimed